XML 29 R11.htm IDEA: XBRL DOCUMENT v3.25.4
Goodwill and Other Intangible Assets
 6 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets
4. Goodwill and Other Intangible Assets
Goodwill
The following table summarizes the changes in the carrying amount of goodwill by segment and in total:
(in millions)Pharmaceutical and Specialty SolutionsGlobal Medical Products and DistributionOther (1)Total
Balance at June 30, 2025
$7,943 $— $1,748 $9,691 
Goodwill acquired, net of purchase price adjustments1,918 — — 1,918 
Balance at December 31, 2025$9,861 $— $1,748 $11,609 
(1) Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight® Logistics.
Goodwill increased in the six months ended December 31, 2025 primarily due to the Solaris acquisition in the Pharma segment. Goodwill recognized in connection with the acquisition primarily represent the expected benefits from the expected growth from new customers, the assembled workforce of the acquired entities and synergies of integrating these businesses. Substantially all of the goodwill recorded is expected to be non-deductible for income tax purposes.
Purchased goodwill is tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount.
As described in Note 2, the purchase price and assumed fair value of acquisitions is allocated to specific assets, resulting in the carrying amount approximating the fair value as of the acquisition date. Accordingly, we expect minimal excess of estimated fair value over carrying value for recent acquisitions. We will continue to evaluate acquisitions and the related reporting units for indicators of impairment.


Other Intangible Assets
The following tables summarize other intangible assets by class at:
December 31, 2025
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents$14 $— $14 N/A
Total indefinite-life intangibles14 — 14 N/A
Definite-life intangibles:
Customer intangibles
3,632 2,720 912 10
Trademarks, trade names and patents1,583 503 1,080 8
Developed technology and other1,030 752 278 6
Non-Competition Agreements
111 26 85 4
Total definite-life intangibles6,356 4,001 2,355 9
Total other intangible assets$6,370 $4,001 $2,369 N/A
June 30, 2025
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible
Indefinite-life intangibles:
Trademarks and patents$13 $— $13 
Total indefinite-life intangibles13 — 13 
Definite-life intangibles:
Customer intangibles
3,876 2,639 1,237 
Trademarks, trade names and patents1,340 459 881 
Developed technology and other1,030 726 304 
Non-Competition Agreements
72 21 51 
Total definite-life intangibles6,318 3,845 2,473 
Total other intangible assets$6,331 $3,845 $2,486 

Total amortization of intangible assets was $84 million and $69 million for the three months ended December 31, 2025 and 2024, respectively, and $171 million and $137 million for the six months ended December 31, 2025 and 2024, respectively.

The following table summarizes the estimated amortization expense for the remainder of fiscal 2026 through fiscal 2030:
(in millions)
Estimated Amortization Expense
2026
$193 
2027382 
2028349 
2029327 
2030306